analysis: MRG RAR TF AHT MRN. Wrote the manuscript: MRG MRN. Provided feedback on the manuscript: RAR TF AHT. References 1. Levy SE, Mandell DS, Schultz RT (2009) Autism. Lancet 374: 1627–1638. 2. Betancur C (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380: 42– 77. 3. Gillis RF, Fouleau GA (2011) The ongoing dissection of the genetic architecture of autism spectrum disorder. Mol Autism 2: 12. 4. Devlin B, Scherer SW (2012) Genetic architecture in autism spectrum disorder. Curr Opin Genet Develop 22: 1–9. 5. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, et al. (2012) De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485: 237–241. 6. Neale BM, Kou Y, Liu L, Ma’ayan A, Samocha KE, et al. (2012) Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485: 242–246. 7. O’Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, et al. (2012) Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485: 246–250. 8. Chahrour MH, Yu TW, Lim ET, Ataman B, Coulter ME, et al. (2012) Whole exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet 8: e1002635. 9. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, et al. (2012) De novo gene disruptions in children on the autistic spectrum. Neuron 74: 285–299. 10. Levitt P, Campbell DB (2009) The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest 119: 747–754. 11. Geschwind DH (2011) Genetics of autism spectrum disorders. Trends Cogn Sci 15: 409–416. 12. Sakai Y, Shaw CA, Dawson BC, Dugas DG, Al-Muhtaseb Z, et al. (2011) Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med 3: 1–10. 13. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, et al. (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474: 380–384. 14. Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha GD, et al. (2012) Consensus paper: pathological role of the cerebellum in autism. Cerebellum 11: 777–807. 15. Ring HA, Baron-Cohen S, Wheelwright S, Williams SC, Brammer M, et al. (1999) Cerebral correlates of preserved cognitive skills in autism: a functional MRI study of embedded figures task performance. Brain 122: 1305–1315. 16. Hazlett EA, Buchsbaum MS, Hsieh P, Haznedar MM, Platholl J, et al. (2004) Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patients. Neuropsychobiology 49: 115–125. 17. Wintle RF, Lionel AC, Hu P, Ginsberg SD, Pinto D, et al. (2011) A genotype resource for postmortem brain samples from the Autism Tissue Program. Autism Res 4: 89–97. 18. Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, et al. (2010) A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 56: 399–408. 19. Voineagu I (2012) Gene expression studies in autism: moving from the genome to the transcriptome and beyond. Neurobiol Dis 45: 69–75. 20. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, et al. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459: 569–573. 21. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, et al. (2010) Functional impact of global rare copy number variation in autism spectrum disorder. Nature 466: 368–372. Transcriptomic and Epigenetic Findings in Autism 22. Sbacchi S, Acquadro F, Caio I, Romano V (2010) Functional annotation of genes overlapping copy number variants in autistic patients: focus on axon pathfinding. Curr Genomics 11: 136–145. 23. Levy D, Ronemus M, Yamron B, Lee YH, Leotta A, et al. (2011) Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70: 886–897. 24. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, et al. (2011) Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70: 898–907. 25. Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, et al. (2010) Mitochondrial dysfunction in autism. JAMA 304: 2389–2396. 26. Haas RH (2010) Autism and mitochondrial disease. Dev Disabil Res Rev 16: 144–153. 27. Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, et al. (2011) Brain region- specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 117: 209–220. 28. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, et al. (2008) Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30: 303–311. 29. Auerbach BD, Osterweil EK, Bear MF (2011) Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480: 63–69. 30. Darnell JC (2011) Defects in translational regulation contributing to human cognitive and behavioral disease. Curr Opin Genet Devel 21: 465–473. 31. Xu H, Lu A, Sharp FR (2011) Regional genome transcriptional response of adult mouse brain to hypoxia. BMC Genomics 12: 499. 32. Xu LM, Li JR, Huang Y, Zhao M, Tang X, et al. (2012) AutismKB: an evidence-based knowledgebase of autism genetics. Nucl Acids Res 40: D1016– D1022. 33. Gregg JP, Lit L, Baron CA, Hertz-Picciotto I, Walker W, et al. (2008) Gene expression changes in children with autism. Genomics 91: 22–29. 34. Onore C, Careaga M, Ashwood P (2012) The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26: 383–392. 35. Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9: 559. 36. Burnstock G, Fredholm BB, Verkhratsky A (2011) Adenosine and ATP receptors in the brain. Curr Top Med Chem 11: 973–1011. 37. Anagnostou E, Taylor MJ (2011) Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here. Mol Autism 2: 4. 38. Cheung C, Chua SE, Cheung V, Khong PL, Tai KS, et al. (2009) White matter fractional anisotrophy differences and correlates of diagnostic symptoms in autism. J Child Psych Psychiatr 50: 1102–1112. 39. Xin Y, Chanrion B, Liu MM, Galfaluy H, Costa R, et al. (2010) Genome-wide divergence of DNA methylation marks in cerebral and cerebellar cortices. PLoS ONE 5: e11357. 40. Nguyen A, Rauch TA, Pfeifer GP, Hu VW (2010) Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J 24: 3036–3051. 41. Jiang YH, Sahoo T, Michaelis RC, Bercovich D, Bressler J, et al. (2004) A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A 131: 1–10. 42. Nagarajan RP, Patzel KA, Martin M, Yarui DH, Swanberg SE, et al. (2008) MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res 1: 169–178. 43. Gregory SG, Connelly JJ, Towers AJ, Johnson J, Biscocho D, et al. (2009) Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 7: 62. PLOS ONE | www.plosone.org 9 September 2012 | Volume 7 | Issue 9 | e44736